Prognostic Impact of the Neutrophil/Lymphocyte Ratio (NLR) in the Treatment of First-line Metastatic or Locally Advanced Breast Cancer Treated With CDK4/6 Inhibitor.

NCT05303129 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

165

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Metastatic Breast Cancer

Interventions

BIOLOGICAL: Blood sampling

Sponsor

Centre Francois Baclesse